The Somerset farm where Sativa is headquartered seems an unlikely location for a highly secure cannabis-growing operation.
The road cuts in between sloping fields dotted with sheep (which I’m told are there as “free lawnmowers”) and leads to a large barn-like building. On the morning I arrive, there is a crisp winter mist hanging over the hills and surrounding villages.
It may not look like it, but this is a key battleground in the fight to get cannabis recognised for its medical uses which, so say Sativa’s bosses, would speed up the growth of an already blooming British industry.
Sativa Group Plc (NEX:SATI) is the UK’s leading quoted CBD Wellness and medicinal cannabis group with five operating subsidiaries. Goodbody Botanicals provides CBD products online and to retail markets including pharmacies, wellness stores and grocers. Goodbody Wellness is a high-street retail brand with dedicated CBD Wellness stores providing a premium shopping experience to consumers. Tessellate Collective is a direct-selling network marketing platform servicing consumers at home. Phytovista laboratories provides independent testing of CBD products to both external customers and fellow Group businesses. Sativa Grow holds a Controlled Drug licence and cultivates cannabis plants to fulfill its partnership agreement with King’s College London to research the impact of cannabinoids on inflammation and respiratory conditions.